wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33633431-02744EEC-D942-4763-B0C4-32ED214F677F
Q33633431-02744EEC-D942-4763-B0C4-32ED214F677F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633431-02744EEC-D942-4763-B0C4-32ED214F677F
Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials.
P2860
Q33633431-02744EEC-D942-4763-B0C4-32ED214F677F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633431-02744EEC-D942-4763-B0C4-32ED214F677F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
72fb91f0b7fd99a06b4b85d8b32f8aeaf3b9ef12
P2860
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma.